PHGE BiomX Inc.
Price Chart
Executive Summary
BiomX Inc. received acceptance from NYSE American of its plan to regain compliance with continued listing standards, granting a plan period through September 25, 2027. The company had a stockholders' deficit of $(1.302 million) as of December 31, 2025 and losses in five recent fiscal years, leading to its non-compliance. While the plan acceptance provides a path to avoid delisting, the underlying financial weakness and high execution risk keep the outlook uncertain.
Actionable Insight
Track the company's progress on its compliance plan, particularly any capital raises or restructuring that could improve equity. Delisting risk remains significant if the plan fails, making PHGE a high-risk, event-driven trade. The extended timeline (2027) reduces near-term urgency.
Key Facts
- NYSE American accepted BiomX's compliance plan on June 10, 2026, with a plan period through September 25, 2027.
- Non-compliance stemmed from stockholders' deficit of $1.302 million as of Dec 31, 2025 and losses from continuing operations in five recent fiscal years.
- The company's stock will continue trading with a .BC (below compliance) indicator during the plan period.
- If the company fails to regain compliance or make sufficient progress, delisting proceedings may be initiated.
Financial Impact
Stockholders' deficit of $1.302 million as of December 31, 2025, with ongoing losses from operations.
Risk Factors
- Failure to execute the compliance plan could lead to delisting and loss of liquidity.
- Continued operating losses may further erode stockholders' equity and worsen compliance.
- Going concern risk given historical losses and negative equity.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-068026 |
| Document: ea029450701ex99-1.htm | 0001213900-26-068026 |
| Document: 0001213900-26-068026-index-headers.html | 0001213900-26-068026 |
| Document: 0001213900-26-068026-index.html | 0001213900-26-068026 |
| Document: 0001213900-26-068026.txt | 0001213900-26-068026 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
2d ago
|
8-K
| $0.7200 awaiting T+5 | awaiting T+5 | — | $0.5360 (−25.56%) |
|
May 28, 2026
17d ago
|
8-K
| $1.56 $0.8680 | ▼ −44.36% | ▼ −44.31% | $0.5360 (−65.64%) |
|
Apr 30, 2026
6w ago
|
10-K/A
| $0.7900 $0.6270 | ▼ −20.63% | ▼ −22.98% | $0.5360 (−32.15%) |
|
Apr 16, 2026
8w ago
|
8-K
| $1.84 $1.11 | ▼ −39.67% | ▼ −40.23% | $0.5360 (−70.87%) |
|
Apr 13, 2026
8w ago
|
8-K
| $2.63 $1.46 | ▼ −44.49% | ▼ −47.78% | $0.5360 (−79.62%) |
|
Apr 13, 2026
8w ago
|
Press Release
| $2.63 $1.46 | ▼ −44.49% | ▼ −47.78% | $0.5360 (−79.62%) |
|
Apr 10, 2026
9w ago
|
8-K
| $2.89 $1.84 | ▼ −36.33% | ▼ −40.84% | $0.5360 (−81.45%) |
|
Apr 10, 2026
9w ago
|
Press Release
| $2.89 $1.84 | ▼ −36.33% | ▼ −40.84% | $0.5360 (−81.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access